Cover Image

Cutaneous sarcoidosis possibly associated with aromatase inhibitors and tamoxifen

Saved in:

Bibliographic Details
Main Authors:	Tomoya Sawada, MD (Author), Saeko Nakajima, MD, PhD (Author), Kenji Kabashima, MD, PhD (Author)
Format:	Book
Published:	Elsevier, 2023-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Aromatase inhibitor for the treatment of primary mucinous carcinoma of the skin with distant metastasis
by: Hideaki Miyachi, MD, PhD, et al.
Published: (2018)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
by: Jeffrey S. Smith, MD, PhD, et al.
Published: (2023)

Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil
by: Mariam Alam, MD, et al.
Published: (2021)

Recalcitrant cutaneous sarcoidosis treated with upadacitinib: Case report
by: Mohannad Safadi, MD, et al.
Published: (2024)

COVID-19 mRNA Vaccine-Associated Uveitis Leading to Diagnosis of Sarcoidosis: Case Report and Review of Literature
by: Toshihiko Matsuo MD, PhD, et al.
Published: (2022)

A case of cutaneous sarcoidosis with pulmonary involvement after SARS-CoV-2 mRNA vaccination
by: Jung Eun Seol, MD, PhD, et al.
Published: (2024)

Chronic recurrent annular neutrophilic dermatosis revealing sarcoidosis
by: Fanny Philibert, BS, et al.
Published: (2020)

Exome sequencing reveals biallelic inactivation of KMT2C in cutaneous apocrine carcinoma: A case report and review of the literature
by: Yui Hirano-Lotman, MD, et al.
Published: (2024)

Recurrent cutaneous squamous cell carcinoma in the occipital scalp with clinical perineural invasion developing jugular foramen syndrome
by: Akiyoshi Senda, MD, et al.
Published: (2023)

Tumorigenic Effects of Tamoxifen on the Female Genital Tract
by: Kaei Nasu M.D., Ph.D, et al.
Published: (2008)

Human papillomavirus-related condyloma on keratinized skinKey message
by: Gyohei Egawa, MD, PhD, et al.
Published: (2022)

Art of prevention: The importance of dermatologic care when using aromatase inhibitors
by: Sara Behbahani, MD, MS, et al.
Published: (2021)

Quantification of granuloma volume and response to treatment in cutaneous sarcoidosis using 3-dimensional high-frequency ultrasound scan
by: Olaf Rodriguez, BS, et al.
Published: (2017)

A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection
by: Hiroka Tomiyasu, et al.
Published: (2021)

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
by: Mathew R. Birnbaum, BS, et al.
Published: (2017)

Morpheaform sarcoidosis: A case presentation of an uncommon cutaneous manifestation of sarcoidosis
by: Kimberly B. Hashemi, MD, et al.
Published: (2021)

The Possible Role of Bruton Tyrosine Kinase Inhibitors in the Treatment of COVID-19: A Review
by: Mitra Rezaei, MD, et al.
Published: (2022)

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
by: Katelyn Singh, BS, et al.
Published: (2021)

Cutaneous sarcoidosis and facial filling: a possible triggering event?
by: Iago Gonçalves Ferreira, et al.
Published: (2022)

Chitotriosidase: Providing confirmation of cutaneous sarcoidosis when angiotensin converting enzyme fails
by: Carlie Reeves, BA, MS, et al.
Published: (2024)

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor
by: Alison H. Kucharik, MD, et al.
Published: (2024)

Aromatase inhibitors in post-menopausal endometriosis
by: Devroey Paul, et al.
Published: (2011)

Aromatase inhibitors in stimulated IVF cycles
by: Tournaye Herman, et al.
Published: (2011)

Cutaneous Sarcoidosis
by: Sayal S.K, et al.
Published: (2001)

Possible risks and benefits of adenomyomectomy on pregnancy outcomes: a retrospective analysisAJOG MFM at a Glance
by: Seisuke Sayama, MD, PhD, et al.
Published: (2023)

Treatment of cutaneous lupus with topical ruxolitinib cream
by: Jonathan J. Park, PhD, et al.
Published: (2022)

Multifocal and recurrent cutaneous pseudolymphoma associated with lamotrigine and review of the literature
by: Soroush Kazemi, BS, et al.
Published: (2022)

Cutaneous findings in myotonic dystrophyCapsule Summary
by: Ha Eun Kong, MD, PhD, et al.
Published: (2022)

Primary cutaneous lymphoma in a patient with mastocytosis: Is there an association?
by: Colin M. Kincaid, BS, et al.
Published: (2023)

Rare presentation of Rothmund-Thomson syndrome with predominantly cutaneous findings
by: Ji Young Yang, MD, et al.
Published: (2017)

Multiple drug sensitization syndrome: A distinct phenotype associated with unrecognized Mycoplasma pneumonia infection
by: Yumi Aoyama, MD, PhD, et al.
Published: (2017)

The emerging use of aromatase inhibitors for endometriosis treatment
by: Nothnick Warren B
Published: (2011)

Potential role of aromatase inhibitors in the treatment of endometriosis
by: Abu Hashim H
Published: (2014)

Aromatase inhibitor strategies in metastatic breast cancer
by: Heather L McArthur, et al.
Published: (2009)

Clinical utilities of aromatase inhibitors in breast cancer
by: Chumsri S
Published: (2015)

Aromatase inhibitors in men: effects and therapeutic options
by: de Jong Frank H, et al.
Published: (2011)

Clinical-histopathological features and cancer gene analysis of cutaneous epithelioid angiosarcoma: A report of 4 cases
by: Keiko Tokuchi, MD, PhD, et al.
Published: (2024)

Koebnerization phenomenon after broadband light therapy in a patient with cutaneous sarcoidosis
by: Jaclyn Chesner, BA, et al.
Published: (2017)

Cutaneous manifestations of sarcoidosis
by: Alka Dogra, et al.
Published: (2012)